Clinical Research
Immuno Cure and PharmaJet Partner on Needle-Free HIV Therapeutic Vaccine Study in Hong Kong
Immuno Cure BioTech ("Immuno Cure"), a clinical-stage biotechnology group based in Hong Kong Science Park, is pleased to announce its upcoming collaboratio...
June 20, 2025 | News
Dizal Completes Enrollment for Global Phase III Trial of Sunvozertinib in EGFR exon20ins NSCLC Patients
Dizal announced the completion of patient enrollment for its WU-KONG28 clinical trial: a multinational, randomized phase III study evaluating the effi...
June 20, 2025 | News
LOTTE BIOLOGICS Expands Global CDMO Footprint with Antibody Therapeutics Deal with Ottimo Pharma
Expanding track record by signing contracts with various global companies across Asia and Europe LOTTE BIOLOGICS announced on June 19, 2025 that it ha...
June 19, 2025 | News
Sartorius Expands Aubagne Campus in France to Boost Global Fluid Management Capabilities
Extended campus at headquarters of French sub-group Sartorius Stedim Biotech in Aubagne Significantly increased capacities for manufacturing, logistics,...
June 19, 2025 | News
Clover Biopharma Begins Phase I Trial of Respiratory Combination Vaccines in Older Adults
Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovat...
June 18, 2025 | News
Pierre Fabre Acquires Global Rights to Next-Generation EGFR Inhibitors for Lung Cancer
Pierre Fabre Laboratories are pleased to announce the acquisition from Antares Therapeutics, Inc. ("Antares"), a spin-out of Scorpion Therapeutics, Inc., o...
June 17, 2025 | News
Thermo Fisher’s Integrated CDMO-CRO Model Cuts Drug Development Time by Up to 34 Months, Finds Tufts CSDD Study
Thermo Fisher Scientific Inc., the world leader in serving science, announced the findings of new research by the Tufts Center for the Study of Drug ...
June 17, 2025 | News
Abbisko Begins Registrational Trial of Irpagratinib, a Precision FGFR4 Inhibitor, for Advanced Liver Cancer
Abbisko Therapeutics announced that it has completed first patient dosing in a registrational study of irpagratinib, a self-developed and highly-selective ...
June 17, 2025 | News
MSD Launches Phase 3 MOBILIZE-1 Trial for Single-Dose Dengue Vaccine V181 in Asia-Pacific
MOBILIZE-1 is the first Phase 3 study being initiated for V181 as part of a planned robust clinical development program Study will evaluate a single dos...
June 16, 2025 | News
Gene Solutions and USKBio Partner to Launch AI-Powered NGS Oncology Lab in Southern China
- Gene Solutions, a leading multinational biotechnology company and Shenzhen USK Bioscience Co., Ltd. (USKBio), a prominent innovator i...
June 16, 2025 | News
Thermo Fisher’s Olink Explore HT Selected by Regeneron Genetics Center for 200,000-Sample Proteomics Study
Thermo Fisher Scientific, the world leader in serving science, today announced that the Regeneron Genetics Center® (RGC™) has selected the O...
June 13, 2025 | News
Deep Apple Therapeutics and Novo Nordisk Join Forces to Develop Next-Gen Oral Therapies for Cardiometabolic Diseases
- Deep Apple Therapeutics Announces Collaboration with Novo Nordisk to Discover and Develop Oral Therapies for Cardiometabolic Diseases The partnership ai...
June 12, 2025 | News
Abbisko Therapeutics’ Pimicotinib NDA Accepted by China NMPA for Tenosynovial Giant Cell Tumor
Abbisko Therapeutics Co., Ltd. announced that the China National Medical Products Administration (NMPA) has accepted the New Drug Application (NDA) f...
June 11, 2025 | News
ClavystBio and A*STAR Join Forces to Accelerate MedTech Venture Creation and Commercialisation in Singapore
ClavystBio, a life sciences investor and venture builder established by Temasek, and the Agency for Science, Technology and Research (A*STAR), S...
June 11, 2025 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
